David Apelian

2016 - Achillion Pharmaceuticals

In 2016, David Apelian earned a total compensation of $1.3M as Executive Vice President and Chief Medical Officer at Achillion Pharmaceuticals, a 84% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$140,060
Option Awards$635,350
Salary$485,500
Other$32,652
Total$1,293,562

Apelian received $635.4K in option awards, accounting for 49% of the total pay in 2016.

Apelian also received $140.1K in non-equity incentive plan, $485.5K in salary and $32.7K in other compensation.

Rankings

In 2016, David Apelian's compensation ranked 6,989th out of 14,075 executives tracked by ExecPay. In other words, Apelian earned more than 50.3% of executives.

ClassificationRankingPercentile
All
6,989
out of 14,075
50th
Division
Manufacturing
2,623
out of 5,489
52nd
Major group
Chemicals And Allied Products
855
out of 1,895
55th
Industry group
Drugs
657
out of 1,538
57th
Industry
Pharmaceutical Preparations
522
out of 1,176
56th
Source: SEC filing on April 17, 2017.

Apelian's colleagues

We found four more compensation records of executives who worked with David Apelian at Achillion Pharmaceuticals in 2016.

2016

Milind Deshpande

Achillion Pharmaceuticals

Chief Executive Officer

2016

Joel Barrish

Achillion Pharmaceuticals

Chief Scientific Officer

2016

Joseph Truitt

Achillion Pharmaceuticals

Executive Vice President and Chief Commercial Officer

2016

Mary Fenton

Achillion Pharmaceuticals

Chief Financial Officer

News

You may also like